SCHEMBL30749598

SCHEMBL30749598

CS(=O)(=O)N1CCN(c2ccc(-n3ncc4ccc(O)cc43)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 7/20 0.51
ALDH1A1 P00352 3/20 0.43
DCTPP1 Q9H773 1/20 0.43
MAP4K1 Q92918 4/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27170833 1.00 LRRK2 (0.51) LRRK2ALDH1A1DCTPP1MAP4K1LMNA
SCHEMBL27170795 0.83 LRRK2 (0.44) LRRK2ALDH1A1DCTPP1MAP4K1LMNA
SCHEMBL17573286 0.82 LRRK2 (0.70) LRRK2ALDH1A1LMNA
SCHEMBL1905445 0.78 MAPT (0.48) ALDH1A1LMNAMEN1MAPTKMT2A
SCHEMBL27170759 0.78 ALDH1A1 (0.42) LRRK2ALDH1A1DCTPP1LMNAMEN1
SCHEMBL2453453 0.77 MAPT (0.59) ALDH1A1LMNAMEN1MAPTKMT2A
SCHEMBL27170782 0.77 ALDH1A1 (0.45) LRRK2ALDH1A1DCTPP1LMNAMEN1
SCHEMBL25366939 0.76 ALDH1A1 (0.41) LRRK2ALDH1A1DCTPP1LMNAMEN1
SCHEMBL27170654 0.75 POLB (0.44) LRRK2ALDH1A1DCTPP1LMNAMEN1
SCHEMBL27170674 0.75 KDM4E (0.41) LRRK2ALDH1A1DCTPP1MAP4K1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083853-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, INC. 2024-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083853-A1 HSD17B13 INHIBITORS AND USES THEREOF HSD17B3, HSD17B11, HSD17B1 LRRK2 4153/4885ALDH1A1 247/4885DCTPP1 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.